Pre-Revenue Pharma / SaaS Hybrid
From Grant to Growth: Pharma Startup Unlocks $12M with Forecast-Ready Financials
How a Pharma Startup Secured $12M with Forecast-Ready Financials
This early-stage pharmaceutical startup had the science and vision — but without revenue or reliable financial reporting, investor confidence was shaky. High churn, poor ARR forecasting, and weak board communication left funding prospects on the line.
“We were innovating fast, but our financial narrative couldn’t keep up. Without a clearer picture, investors weren’t buying in.”
The Pain Points
Churn was high, threatening recurring revenue stability
ARR projections were off, limiting planning and resource allocation
Board reports lacked clarity, risking credibility with investors
Without improvements, their next funding round was slipping out of reach.
The Adea Fix
✅ Churn Prediction Models Deployed
We implemented machine learning models that flagged at-risk customers, enabling proactive retention strategies and cutting churn before it cut revenue.
✅ Deferred Revenue Tracking Upgraded
We rebuilt their tracking systems for accuracy, giving the team visibility into future revenue streams and making their ARR projections investor-grade.
✅ Board-Ready Financial Reports Delivered
Professional dashboards and automated reporting tools turned complex data into clean, compelling presentations that instilled investor trust.
The Results
📉 18% reduction in churn
📈 25% boost in ARR forecast accuracy
💰 $12M in funding raised
“We didn’t just improve our numbers — we proved we were ready to grow. That’s what closed the round.”
📊 Is your startup ready for the next round — or just hoping for it?
Let Adea build the financial foundation that helps you scale with confidence.
You might also be interested in
Healthcare
Healthcare
